Effectiveness of Onabotulinumtoxin A on Reduction of Rest Tremor in Parkinson's Disease: a Pilot Study
Phase of Trial: Phase I
Latest Information Update: 02 Apr 2018
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 23 Mar 2018 Planned End Date changed from 1 Jun 2019 to 1 Mar 2019.
- 23 Mar 2018 Planned primary completion date changed from 1 Jun 2019 to 1 Mar 2019.
- 23 Mar 2018 Status changed from not yet recruiting to recruiting.